XML 92 R78.htm IDEA: XBRL DOCUMENT
v3.24.2

Equity - Summary of the Warrants (Parenthetical) (Details) - $ / shares | Dec. 31, 2023 | Apr. 10, 2023
--- | --- | ---
Stockholders Equity Details [Line Items] |  |  |
Exercise per share price (in Dollars per share) |  |  | $ 7.5
Dragasac Warrant |  |  |
Stockholders Equity Details [Line Items] |  |  |
Exercise per share price (in Dollars per share) | [1] | $ 67.7 |
Dragasac Warrant | Class A Common Stock |  |  |
Stockholders Equity Details [Line Items] |  |  |
Exercise per share price (in Dollars per share) |  | $ 67.7 |
Warrants per share, percentage |  | 80.00% |
Public Warrants |  |  |
Stockholders Equity Details [Line Items] |  |  |
Exercise per share price (in Dollars per share) | [2] | $ 115 |
Warrants outstanding |  | 14,374,478 |
Public Warrants | Class A Common Stock |  |  |
Stockholders Equity Details [Line Items] |  |  |
Exercise per share price (in Dollars per share) |  | $ 115 |
Sponsor Warrants |  |  |
Stockholders Equity Details [Line Items] |  |  |
Exercise per share price (in Dollars per share) | [2] | $ 115 |
Warrants outstanding |  | 8,499,999 |
Sponsor Warrants | Class A Common Stock |  |  |
Stockholders Equity Details [Line Items] |  |  |
Exercise per share price (in Dollars per share) |  | $ 115 |
[1] | The exercise price is the lesser of $67.70 per share or 80% of either (i) the value attributed to one share of Legacy Celularity Series B Preferred Stock upon consummation of a change in control or the closing of a strategic transaction or (ii) the price at which one share of common stock is sold to the public market in an initial public offering.
[2] | The number of Public Warrants and Sponsor Warrants outstanding was not adjusted for the reverse stock split. There are 14,374,478 Public Warrants and 8,499,999 Sponsor Warrants outstanding. After the reverse stock split, the number of warrants outstanding remains the same. However, each outstanding warrant is now exercisable for one-tenth of a share of Class A common stock, and the exercise price per share was adjusted to $115.00 as a result of the split.

X
- Definition Stockholders’ Equity (Details) [Line Items] + References No definition available. + Details
Name: | celu_StockholdersEquityDetailsLineItems
Namespace Prefix: | celu_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants outstanding. + References No definition available. + Details
Name: | celu_WarrantsOutstanding
Namespace Prefix: | celu_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Warrants per share, percentage. + References No definition available. + Details
Name: | celu_WarrantsPerSharePercentage
Namespace Prefix: | celu_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_DragasacWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_PublicWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_SponsorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |